Watson Pharmaceuticals: Company Profile

Watson Pharmaceuticals: Company Profile
  • Report price : $ 350
  • Publication date : June 2008
  • Length : 25 pages

Get this Report Now !

Watson Pharmaceuticals: Company Profile

This company profile offers a comprehensive analysis of the organization, its business segments, and competitors. It analyzes the business and marketing strategies adopted by the company, to gain a competitive edge in the industry. The profile also evaluates the strengths of the company and the opportunities present in the market.

This profile is of immense help to management consultants, analysts, market research organizations and corporate advisors.

The objective and scope of various sections of our company profile has been discussed below.

Company Summary
This section presents the key facts & figures, business description, products & services offered and corporate timeline of the company.

Company Analysis
It involves analysis of the company at three levels – segments, organizational structure and ownership composition. Both business and geographic segments are analyzed alongwith their recent financial performance. It further discusses the major subsidiaries of the company and the recent merger & acquisitions.

Business Developments
This section examines the significant developments that have taken place in the company. It is a form of news analysis where the most critical company news is discussed.

Discussion of Business Strategies
This section talks about the current and future strategies of the company. All business, marketing, financial and organizational strategies are discussed here.

SWOT
Our SWOT Analysis is a valuable step in assessing your company's strengths, weaknesses, opportunities, and threats. It offers powerful insight into the critical issues affecting a business.

Financial Performance
It discusses the most recent financials of the company and also compares the historical sales & income figures with the current and projected figures. The objective is to evaluate the financial health of the company. The analyst opinion and stock performance help us in evaluating the performance of the company from an investor’s viewpoint.

Competition Synopsis
This section compares the company with its peer group. The comparable analysis and stock movement are aimed at giving an overview of the competitive landscape in the industry and the company’s positioning in its peer group.

RELATED REPORTS

Toray Industries, Inc.: Competitive Intelligence

Toray Industries, Inc.: Competitive Intelligence

  • $ 800
  • June 2008
  • 35 pages

This Competitive Intelligence Report helps you to know more about your company, your industry, and your competitors. It makes you better informed about important issues like launching a new product or service in the market. It also identifies your competitors' strengths, weaknesses, strategies, and ...

Industries : Chemical, Pharmaceutical, Clothing and Textile | Countries : USA

Toray Industries, Inc.: Company Profile

Toray Industries, Inc.: Company Profile

  • $ 350
  • June 2008
  • 25 pages

This company profile offers a comprehensive analysis of the organization, its business segments, and competitors. It analyzes the business and marketing strategies adopted by the company, to gain a competitive edge in the industry. The profile also evaluates the strengths of the company and the oppo ...

Industries : Chemical, Pharmaceutical, Clothing and Textile | Countries : USA

The Jean Coutu Group (PJC) Inc.: Competitive Intelligence

The Jean Coutu Group (PJC) Inc.: Competitive Intelligence

  • $ 800
  • June 2008
  • 35 pages

This Competitive Intelligence Report helps you to know more about your company, your industry, and your competitors. It makes you better informed about important issues like launching a new product or service in the market. It also identifies your competitors' strengths, weaknesses, strategies, and ...

Industries : Pharmaceutical | Countries : USA

The Jean Coutu Group (PJC) Inc.: Company Profile

The Jean Coutu Group (PJC) Inc.: Company Profile

  • $ 350
  • June 2008
  • 25 pages

This company profile offers a comprehensive analysis of the organization, its business segments, and competitors. It analyzes the business and marketing strategies adopted by the company, to gain a competitive edge in the industry. The profile also evaluates the strengths of the company and the oppo ...

Industries : Pharmaceutical | Countries : USA

SUZUKEN CO., LTD.: Competitive Intelligence

SUZUKEN CO., LTD.: Competitive Intelligence

  • $ 800
  • June 2008
  • 35 pages

This Competitive Intelligence Report helps you to know more about your company, your industry, and your competitors. It makes you better informed about important issues like launching a new product or service in the market. It also identifies your competitors' strengths, weaknesses, strategies, and ...

Industries : Manage Care, Pharmaceutical, Software | Countries : USA

Watson Pharmaceuticals: Competitive Intelligence

Watson Pharmaceuticals: Competitive Intelligence

  • $ 800
  • June 2008
  • 35 pages

This Competitive Intelligence Report helps you to know more about your company, your industry, and your competitors. It makes you better informed about important issues like launching a new product or service in the market. It also identifies your competitors' strengths, weaknesses, strategies, and ...

Industries : Pharmaceutical | Countries : USA

Top Companies and Products in the RNA/DNA Therapy Products Market Forecasts: The challenge of turning technology into therapy

Top Companies and Products in the RNA/DNA Therapy Products Market Forecasts: The challenge of turning technology into therapy

  • $ 4 380
  • July 2007
  • 198 pages

Increasingly the large pharmaceutical companies are pumping money and ambition into the DNA/RNA therapy market. Whether its through forming collaboration/licensing agreements, or acquiring smaller companies they can see the financial opportunities. In particular the large pharmaceutical companies Pf ...

Industries : Pathology, Biotechnology, Pharmaceutical | Countries : USA

Anti-Obesity Treatments 2007-2012 – A blockbuster target market

Anti-Obesity Treatments 2007-2012 – A blockbuster target market

  • $ 3 906
  • July 2007
  • 168 pages

“By 2010, almost 50 percent of children in North America and 38 percent of those in the European Union will be overweight, researcher has found”. For pharmaceutical companies looking to target growing successful markets, the anti-obesity drug treatment market offers unique opportunities.This hi ...

Industries : Pharmaceutical, Pathology | Countries : USA, Japan, Germany, United Kingdom

Global Smoking Cessation Market Analysis & Forecasts - Preparing for the first blockbuster

Global Smoking Cessation Market Analysis & Forecasts - Preparing for the first blockbuster

  • $ 3 358
  • July 2007
  • 151 pages

Cigarette smoking is the most important source of preventable and premature morbidity worldwide. Currently, the number of smokers across the globe is estimated at 1.3 billion. Political moves are leading to national bans of smoking in public places, with the long-term aim to reduce the cost to the h ...

Industries : Pharmaceutical | Countries : Canada, USA, Japan, Sweden, Germany, Spain, France, Italy, United Kingdom, Australia

Parallel Trade - US Lawmakers allow imported prescriptions drugs

Parallel Trade - US Lawmakers allow imported prescriptions drugs

  • $ 3 358
  • June 2007
  • 143 pages

``Parallel Trade acts as an important driving force for market integration where there are important differences in price between member states``- European Commission Communication on the single market in pharmaceuticalsParallel trade is on the verge of breaking its confines of the EU and diffusing ...

Industries : Pharmaceutical | Countries : Mexico, Canada, USA, Cyprus, Denmark, Norway, Sweden, Germany, United Kingdom

reportlinker.com © Copyright 2009. All rights reserved

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.